FILD: immunology, medicine.
SUBSTANCE: invention relates to the methods for molecular diagnostic and can be used in immunology and medicine for accessing immune status by PCR. Present invention is multiparametric diagnostic test system aimed at quantitative determination of the levels of mRNA of human interferons I, II and III types in a biological sample. In particular, the system consists of two samples-A and B, in each of which several reactions take place simultaneously: in sample A-determination of the expression levels of IFN-α, IFN-β and IFN – γ of a person, in sample B-simultaneous determination of the expression of four subtypes of IFN-λ of a person.
EFFECT: proposed system allows differentially determining three subtypes (1, 2/3 and 4, respectively) of IFN-λ, as well as determining the expression of any of the 14 existing subtypes of IFN-α (without determination into subtypes).
4 cl, 3 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
TEST SYSTEM FOR QUANTITATIVE DIAGNOSTICS OF MOUSE OAS1a/g, IL-6, IRF-7, IFNA, IFNB, IFNL GENES BY REAL-TIME PCR | 2022 |
|
RU2796522C1 |
SET OF REAGENTS FOR THE DETERMINATION OF RIBONUCLEIC ACIDS IN THE DIAGNOSIS OF LYMPHOPROLIFERATIVE DISEASES | 2023 |
|
RU2802064C1 |
TEST SYSTEM FOR QUANTITATIVE DIAGNOSTICS OF HUMAN MRNA OF MXA, OAS1, EIF2AK2 GENES BASED ON PCR | 2022 |
|
RU2811690C1 |
SET OF STR-MARKERS OF THE Y-CHROMOSOME FOR DETERMINING THE ETHNO-TERRITORIAL ORIGIN OF AN INDIVIDUAL BASED ON A SAMPLE OF HIS DNA | 2021 |
|
RU2804433C2 |
TEST SYSTEM AND METHOD FOR DETECTING DELETIONS OF THE LONG ARM OF CHROMOSOME 6 | 2021 |
|
RU2770892C1 |
TEST SYSTEM AND METHOD FOR DETECTING SESN1 GENE DELETIONS | 2021 |
|
RU2772504C1 |
SET OF OLIGONUCLEOTIDE PRIMERS AND FLUORESCENTLY MARKED PROBE IN TAQMAN FORMAT FOR DETECTION OF VIRUSES OF FLAVIVIRUS GENUS BY REAL-TIME PCR | 2022 |
|
RU2808520C1 |
ESSC-TIPE-1TEST-SYSTEM FOR MOLECULAR-GENETIC TYPING OF SQUAMOUS OESOPHAGEAL CANCER | 2020 |
|
RU2742468C1 |
METHOD OF DETECTING DNAJB1-PRKACA CHIMERIC TRANSCRIPT IN CLINICAL TISSUE SAMPLES FROM PATIENTS WITH FIBROLAMELLAR LIVER CARCINOMA USING REAL-TIME POLYMERASE CHAIN REACTION | 2023 |
|
RU2807306C1 |
GENETIC MARKERS FOR PREDICTING SENSITIVITY TO THERAPY | 2014 |
|
RU2809215C2 |
Authors
Dates
2021-07-16—Published
2020-12-26—Filed